viernes, 4 de octubre de 2013

The Cardiovascular Safety of Diabetes Drugs —


PERSPECTIVE

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience


http://www.nejm.org/doi/full/10.1056/NEJMp1309610

No hay comentarios:

Publicar un comentario